Leveraging Novel MS Biomarkers to Decode Disease Heterogeneity & Treatment Response for Precision Therapeutic Development
Time: 9:15 am
day: Conference Day Two
Details:
- Identifying novel MS biomarkers to predict individual risk, enabling personalized prevention strategies
- Validating progression-linked biomarkers that track disease severity, to optimize treatment timing and selection
- Linking biomarkers to therapeutic response for emerging drugs to accelerate clinical trial success and approval
